Cargando…

Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance

Epilepsy is a neurological disorder affecting around 1%–2% of population worldwide and its treatment includes use of antiepileptic drugs to control seizures. Failure to respond to antiepileptic drug therapy is a major clinical problem and over expression of ATP-binding cassette transporters is consi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grewal, Gurpreet Kaur, Kukal, Samiksha, Kanojia, Neha, Saso, Luciano, Kukreti, Shrikant, Kukreti, Ritushree
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155434/ https://www.ncbi.nlm.nih.gov/pubmed/28264441 http://dx.doi.org/10.3390/molecules22030365

Ejemplares similares

In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2
por: Grewal, Gurpreet Kaur, et al.
Publicado: (2017)

Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
por: Singh, Anju, et al.
Publicado: (2019)

Oxidative Stress: Role and Response of Short Guanine Tracts at Genomic Locations
por: Singh, Anju, et al.
Publicado: (2019)

Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes
por: Singh, Anju, et al.
Publicado: (2022)

Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
por: Rawat, Chitra, et al.
Publicado: (2019)

Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile
por: Mishra, Manish Kumar, et al.
Publicado: (2021)

Viral Induced Oxidative and Inflammatory Response in Alzheimer’s Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach
por: Talwar, Puneet, et al.
Publicado: (2019)

Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy
por: Rawat, Chitra, et al.
Publicado: (2020)

Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment
por: Thakran, Sarita, et al.
Publicado: (2020)

Human genetic factors associated with pneumonia risk, a cue for COVID-19 susceptibility
por: Guin, Debleena, et al.
Publicado: (2022)

Glutamate transporter genes are associated with schizophrenia in South Indian population
por: Jajodia, Ajay, et al.
Publicado: (2014)

Genetic polymorphism of drug refractory epilepsy
por: Kesavan, R., et al.
Publicado: (2011)

Structural Switch from Hairpin to Duplex/Antiparallel G-Quadruplex at Single-Nucleotide Polymorphism (SNP) Site of Human Apolipoprotein E (APOE) Gene Coding Region
por: Chaudhary, Swati, et al.
Publicado: (2018)

Challenges and recommendations for conducting epidemiological studies in the field of epilepsy pharmacogenetics
por: Grover, Sandeep, et al.
Publicado: (2011)

Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk
por: Srivastava, Ankit, et al.
Publicado: (2019)

A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson’s disease
por: Guin, Debleena, et al.
Publicado: (2017)

Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?
por: Czornyj, Liliana, et al.
Publicado: (2021)

Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies
por: Verma, Sagar, et al.
Publicado: (2021)

Evaluation of genetic association of neurodevelopment and neuroimmunological genes with antipsychotic treatment response in schizophrenia in Indian populations
por: Jajodia, Ajay, et al.
Publicado: (2015)

Association of serotonin transporter (SLC6A4) & receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study
por: Basu, Aniruddha, et al.
Publicado: (2015)

Cortical stimulation in pharmacoresistant focal epilepsies
por: Ellrich, Jens
Publicado: (2020)

Genetic variations associated with pharmacoresistant epilepsy
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2020)

Validating a Genomic Convergence and Network Analysis Approach Using Association Analysis of Identified Candidate Genes in Alzheimer’s Disease
por: Talwar, Puneet, et al.
Publicado: (2021)

Vagal nerve stimulation for pharmacoresistant epilepsy in children
por: Hauptman, Jason S., et al.
Publicado: (2012)

Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2022)

Gender Specific Association of RAS Gene Polymorphism with Essential Hypertension: A Case-Control Study
por: Dhanachandra Singh, Kh., et al.
Publicado: (2014)

Pharmacoresistant Abdominal Seizures in Symptomatic Localization-Related Epilepsy
por: Tushar, Vadakke Puthanveetil, et al.
Publicado: (2021)

The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies
por: Fattorusso, Antonella, et al.
Publicado: (2021)

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2023)

Structural polymorphism exhibited by a quasipalindrome present in the locus control region (LCR) of the human β-globin gene cluster
por: Kaushik, Mahima, et al.
Publicado: (2006)

Homoduplex to i-motif structural switch exhibited by a cytosine rich strand of the MYH7 heavy chain β gene promoter at physiological pH
por: Singh, Anju, et al.
Publicado: (2018)

A complex systems view on the current hypotheses of epilepsy pharmacoresistance
por: Servilha‐Menezes, Gabriel, et al.
Publicado: (2022)

Genetic Variations of PIP4K2A Confer Vulnerability to Poor Antipsychotic Response in Severely Ill Schizophrenia Patients
por: Kaur, Harpreet, et al.
Publicado: (2014)

Effect of apolipoprotein E (APO E) polymorphism on leptin in Alzheimer's disease
por: Agarwal, Rachna, et al.
Publicado: (2015)

Synergistic association of STX1A and VAMP2 with cryptogenic epilepsy in North Indian population
por: Baghel, Ruchi, et al.
Publicado: (2016)

Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy
por: Yoon, Jung-Rim, et al.
Publicado: (2013)

7T MRI with post-processing for the presurgical evaluation of pharmacoresistant focal epilepsy
por: Chen, Cong, et al.
Publicado: (2021)

‘Hippocampal innate inflammatory gliosis only’ in pharmacoresistant temporal lobe epilepsy
por: Grote, Alexander, et al.
Publicado: (2022)

Limbic network co‐localization predicts pharmacoresistance in dysplasia‐related epilepsy
por: Cohen, Nathan T., et al.
Publicado: (2023)

A novel G·G·T non-conventional intramolecular triplex formed by the double repeat sequence of Chlamydomonas telomeric DNA
por: Bansal, Aparna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_adbrifhjkg05a1a7hilvpv7qbr